Cytek Biosciences is a medical devices business based in the US. Cytek Biosciences shares (CTKB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.86 – an increase of 2.39% over the previous week. Cytek Biosciences employs 648 staff and has a trailing 12-month revenue of around $200.5 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $3.86 |
|---|---|
| 52-week range | $3.27 - $7.63 |
| 50-day moving average | $4.21 |
| 200-day moving average | $5.43 |
| Wall St. target price | $6.70 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.05 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $3.86 from 2025-05-02
| 1 week (2025-04-25) | 2.39% |
|---|---|
| 1 month (2025-04-04) | 4.04% |
| 3 months (2025-02-05) | -31.19% |
| 6 months (2024-11-05) | -29.04% |
| 1 year (2024-05-03) | -37.94% |
|---|---|
| 2 years (2023-05-04) | -67.81% |
| 3 years (2022-05-04) | 9.65 |
| 5 years (2020-05-01) | N/A |
| Revenue TTM | $200.5 million |
|---|---|
| Operating margin TTM | 0.67% |
| Gross profit TTM | $111.1 million |
| Return on assets TTM | -2.91% |
| Return on equity TTM | -1.53% |
| Profit margin | -3% |
| Book value | $3.06 |
| Market Capitalization | $494.5 million |
TTM: trailing 12 months
We're not expecting Cytek Biosciences to pay a dividend over the next 12 months.
You may also wish to consider:
Over the last 12 months, Cytek Biosciences's shares have ranged in value from as little as $3.27 up to $7.63. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cytek Biosciences's is 1.413. This would suggest that Cytek Biosciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
To put Cytek Biosciences's beta into context you can compare it against those of similar companies.
Cytek Biosciences, Inc. , a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. It serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. The company distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
These are the stocks to buy when you don’t have much to spend.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Compare pros, cons, research tools and reviews for these two trading platforms.
Some of the best trading apps like Robinhood are SoFi, Tastytrade, Public, eToro, Acorns, Interactive Brokers, E*TRADE and more.
Compare pros, cons, research tools and reviews for these two trading platforms.
SoFi Invest is a no-fee commissions platform with both active and automated investment accounts.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.